Literature DB >> 864260

The effect of BCG on experimental cutaneous leishmaniasis in mice.

J Weintraub, F I Weinbaum.   

Abstract

The effect of administration of live Bacillus Calmette-Guerin (BCG), a nonspecific immunostimulant, on the course of experimental cutaneous leishmaniasis in mice was investigated. BALB/c mice were injected in the footpad with Leishmania tropica, NIH S-strain; in mice that were not pretreated with BCG this produced a reproducible fatal infection characterized by local inflammation, regional lymphadenopathy, and dissemination of parasites with hepatosplenomegaly. In mice that were pretreated with BCG and similarly infected with L. tropica there was a reduction in the severity of cutaneous disease and a significant (p less than 0.005) decrease in mortality without evidence of visceralization.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 864260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Alterations of the immune response associated with chronic experimental leishmaniasis.

Authors:  B Arredondo; H Pérez
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  [Suppression of parasitemia in rodent filariasis (Litomosoides carinii) by immunization with BCG and microfilaria. I. Intracutaneous inoculation of BCG].

Authors:  P Kimmig; P Wenk
Journal:  Z Parasitenkd       Date:  1982

4.  Single gene control of resistance to cutaneous leishmaniasis in mice.

Authors:  L J DeTolla; P A Scott; J P Farrell
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Comparative study of American cutaneous leishmaniasis and diffuse cutaneous leishmaniasis in two strains of inbred mice.

Authors:  H Pérez; B Arredondo; M González
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

6.  Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major.

Authors:  M Nasseri; F Z Modabber
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.

Authors:  Rajesh Ravindran; Sudipta Bhowmick; Amrita Das; Nahid Ali
Journal:  BMC Microbiol       Date:  2010-06-24       Impact factor: 3.605

8.  Studies on visceral Leishmania tropica infection in BALB/c mice. I. Clinical features and cellular changes.

Authors:  J Djoko-Tamnou; C Leclerc; F Modabber; L Chedid
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

9.  Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.

Authors:  J O Hill; R J North; F M Collins
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.

Authors:  G F Grimaldi; P L Moriearty; R Hoff
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.